Left Continue shopping
Your Order

You have no items in your cart

May we Recommend...
From $207.00
Add to cart
Proud Family History - AED Professionals
Thank you for choosing AED Professionals!
From Our Family to Yours, We Truly Appreciate it!
Narcan in the Workplace: The Employer's Guide to Naloxone - AED Professionals

Narcan in the Workplace: The Employer's Guide to Naloxone

For years, workplace emergency planning meant fire, cardiac arrest, and injury. The opioid crisis added a fourth category — and it did not ask permission. The National Safety Council reports that unintentional overdose has become one of the leading causes of workplace fatality, with tens of thousands of opioid-involved deaths nationally each year. These events happen in warehouses, restrooms, parking lots, construction sites, and office buildings. The question for employers is no longer whether overdose response belongs in the emergency plan. It is whether the plan is ready before it's needed.

What Narcan Is — and Why It Changed the Equation

Narcan is the best-known brand of naloxone, an opioid antagonist that rapidly reverses the respiratory depression that makes opioid overdoses fatal. Administered as a simple nasal spray, it requires no medical training, no needles, and no diagnosis — and it is now available over the counter, which removed the last practical barrier to workplace stocking.

Two properties make naloxone uniquely suited to bystander response:

  • It is safe if you're wrong. Naloxone has no meaningful effect on a person who has not taken opioids. If someone is unresponsive and you administer Narcan unnecessarily, you have not harmed them.
  • It works fast. Administered in time, naloxone can restore breathing within two to three minutes — buying the window EMS needs to arrive.

Recognizing an Opioid Overdose

The signs an untrained responder can identify:

  • Unresponsiveness — the person cannot be woken by voice or firm sternal rub
  • Slow, shallow, gurgling, or stopped breathing
  • Pinpoint pupils
  • Blue or gray lips and fingertips
  • Limp body, pale or clammy skin

The Response Sequence

  1. Call 911 first. Naloxone is a bridge to professional care, not a substitute for it.
  2. Administer the nasal spray — insert the nozzle into one nostril and press the plunger firmly. The device delivers a full dose in one press.
  3. Begin rescue breathing or CPR if the person is not breathing. Opioid overdose kills through oxygen deprivation; breathing support saves lives while the medication takes effect.
  4. Give a second dose after 2–3 minutes if there is no response. Stronger synthetic opioids like fentanyl often require multiple doses.
  5. Place the person in the recovery position (on their side) once breathing resumes, and stay with them until EMS arrives. Naloxone wears off before many opioids do — the person can slip back into overdose.

Every state has some form of Good Samaritan protection covering naloxone administration in good faith, and most states explicitly authorize third-party and organizational possession. As with any policy matter, confirm the specifics for your state — but the legal environment has moved decisively in favor of workplace naloxone programs.

Building a Workplace Naloxone Program

A credible program has four components, and none of them are complicated:

  • Stock it — naloxone stored with, or beside, your AED and first aid station, in a temperature-appropriate location, with expiration dates tracked the same way you track AED pad expirations. For public-facing facilities, dedicated public access naloxone cabinets make the medication visible and available.
  • Sign it — responders can't use what they can't find. Label the emergency station clearly.
  • Train it — a 15-minute awareness module covers recognition and administration. Fold it into your existing CPR/AED training cycle.
  • Document it — a one-page policy covering storage location, responsible parties, and replacement procedure satisfies most compliance reviews.

Organizations that already maintain AED programs have a head start: the same logic, the same station, the same training rhythm, the same expiration-tracking discipline. Naloxone is an addition, not a new system.

Add overdose response to your emergency readiness program. AED Professionals supplies Narcan nasal spray and public access naloxone cabinets for workplace, school, and community deployment — with guidance on storage and protocols. Call 888-541-2337 or visit aedprofessionals.com.

Frequently Asked Questions

Can my business legally stock Narcan?

Yes. Naloxone nasal spray is available over the counter in the United States, and every state provides some form of Good Samaritan or third-party administration protection. Many states explicitly encourage organizational stocking. Confirm your state's specific provisions, but the legal framework broadly supports workplace naloxone programs.

What happens if I give Narcan to someone who isn't overdosing?

Essentially nothing. Naloxone only acts on opioid receptors — it has no significant effect on a person without opioids in their system. This safety profile is why national guidance encourages administering it whenever opioid overdose is suspected in an unresponsive person.

How many doses of Narcan should a workplace keep?

At minimum, a two-dose carton per emergency station. Stronger synthetic opioids such as fentanyl frequently require a second dose, and naloxone's effect can wear off before the opioid does. Larger facilities should scale stations the way they scale AED placement — by response-time coverage.

Does Narcan expire?

Yes — naloxone nasal spray typically carries a shelf life of three to four years. Track expiration dates the same way you track AED electrode pads and batteries, and replace on schedule so the station is always response-ready.

AED Professionals: A General Medical Devices, Inc. company

348 W. Colfax Street, Palatine, IL 60067

info@aedprofessionals.com 847-202-3233

Subscribe to our newsletter. 

Provide your email for exclusive promotions, updates and more!

Thanks for contacting us. We'll get back to you as soon as possible.

By subscribing to our newsletter you agree to our privacy policy and will get commercial communication

Copyright © 2004-2024 General Medical Devices, Inc.

All Rights Reserved

Organizations Close to Our Hearts